Zoledronic acid
0,8 mg/ml, 5 ml № 1, № 5, № 10
Group of action
Active ingredient
Dosage form
Concentrate for solution for infusion
ATC code
М05ВА08
RX/OTC
RX
Marketing authorisation no.
UA/16730/01/01
General properties
Pharmacotherapeutic group
Means affecting the structure and mineralization of bones. Bisphosphonates.
Indications
- Prevention of symptoms associated with damage to the bone tissue (pathological fractures, compression of the spinal trunk, complications after surgical interventions and radiation therapy, or hypercalcemia caused by a malignant tumor) in patients with malignant tumors in the later stages.
- Treatment of hypercalcemia caused by a malignant tumor.
Pharmaceutical characteristics
Basic physical and chemical properties
Transparent colorless liquid.
Shelf life
2 years.
Storage conditions
Store in original packaging at a temperature not higher than 25 °C. Keep out of the reach of children.
Manufacturer
PJSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.
